Bioequivalence Study of Nabumetone 750 mg Tablets of Dr. Reddy's Under Fasting Conditions
Status:
Completed
Trial end date:
2006-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is:
- To Assess the bioequivalence study of Nabumetone 750 mg tablets and Relafen® 750 mg
tablets in healthy, adult, human subjects under fasting conditions with a washout period
of 14 days.
- To monitor adverse events and ensure the safety of subjects.